activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2470186	CHEMBL1034135	Inhibition of ERK5 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5332	Homo sapiens	INH	%	10.0
	2470186	CHEMBL1034135	Inhibition of ERK5 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5332	Homo sapiens	INH	%	10.0
	2906180	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906181	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906182	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906183	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906184	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906185	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	650.0	CHEMBL5332	Homo sapiens	Kd	nM	650.0
	2906186	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906187	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906188	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906189	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906190	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906191	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906192	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906193	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906194	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	620.0	CHEMBL5332	Homo sapiens	Kd	nM	620.0
	2906195	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906196	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906197	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906198	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906199	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	520.0	CHEMBL5332	Homo sapiens	Kd	nM	520.0
	2906200	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906201	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906202	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906203	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906204	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906205	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906206	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906207	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906208	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906209	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906210	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906211	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906212	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1600.0	CHEMBL5332	Homo sapiens	Kd	nM	1600.0
	2906213	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906214	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906215	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906216	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2906217	CHEMBL1063799	Binding constant for ERK5 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	2921342	CHEMBL1053723	Inhibition of ERK5 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	95.0	CHEMBL5332	Homo sapiens	Activity	%	95.0
	3203240	CHEMBL1101124	Inhibition of ERK5	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	5600.0	CHEMBL5332	Homo sapiens	Kd	uM	5.6
	3213924	CHEMBL1114880	Inhibition of ERK5 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-8.0	CHEMBL5332	Homo sapiens	INH	%	-8.0
	3331935	CHEMBL1169225	Inhibition of ERK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	3333350	CHEMBL1169225	Inhibition of ERK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	3334755	CHEMBL1169225	Inhibition of ERK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	3336175	CHEMBL1169225	Inhibition of ERK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	3340703	CHEMBL1169225	Inhibition of ERK5 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	3342119	CHEMBL1169225	Inhibition of ERK5 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	3358570	CHEMBL1174415	Inhibition of ERK5 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	71.0	CHEMBL5332	Homo sapiens	INH	%	71.0
	3359012	CHEMBL1174415	Inhibition of ERK5 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	36.0	CHEMBL5332	Homo sapiens	INH	%	36.0
	3445110	CHEMBL1244832	Binding affinity to ERK5	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1100.0	CHEMBL5332	Homo sapiens	Kd	nM	1100.0
	3448428	CHEMBL1244832	Binding affinity to ERK5	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	3448752	CHEMBL1244832	Binding affinity to ERK5	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	3449664	CHEMBL1244832	Binding affinity to ERK5	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	3450077	CHEMBL1244832	Binding affinity to ERK5	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	3450340	CHEMBL1244832	Binding affinity to ERK5	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	3450997	CHEMBL1244832	Binding affinity to ERK5	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
	5203013	CHEMBL1670769	Inhibition of human recombinant ERK5 in cell free system after 90 mins	B	COc1cc(O)c2c(c1)/C=C/C[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1668411	>	IC50	nM	100000.0	CHEMBL5332	Homo sapiens	IC50	uM	100.0
	5223286	CHEMBL1679280	Binding affinity to ERK5 at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2		CHEMBL1672987	>	Inhibition	%	90.0	CHEMBL5332	Homo sapiens	INH	%	90.0
	5223287	CHEMBL1679280	Binding affinity to ERK5 at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	>	Inhibition	%	90.0	CHEMBL5332	Homo sapiens	INH	%	90.0
	5223305	CHEMBL1679295	Binding affinity to ERK5 by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2		CHEMBL1672987	>	Kd	nM	670.0	CHEMBL5332	Homo sapiens	Kd	nM	670.0
	5223311	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	=	Inhibition	%	82.0	CHEMBL5332	Homo sapiens	INH	%	82.0
	5223312	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673040	=	Inhibition	%	73.0	CHEMBL5332	Homo sapiens	INH	%	73.0
	5223313	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCOCC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673041	=	Inhibition	%	65.0	CHEMBL5332	Homo sapiens	INH	%	65.0
	5223314	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCNCC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673042	=	Inhibition	%	75.0	CHEMBL5332	Homo sapiens	INH	%	75.0
	5223315	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673043	=	Inhibition	%	80.0	CHEMBL5332	Homo sapiens	INH	%	80.0
	5223316	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673044	=	Inhibition	%	67.0	CHEMBL5332	Homo sapiens	INH	%	67.0
	5223317	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	Cc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673045	=	Inhibition	%	60.0	CHEMBL5332	Homo sapiens	INH	%	60.0
	5223318	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673046	=	Inhibition	%	76.0	CHEMBL5332	Homo sapiens	INH	%	76.0
	5223319	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21		CHEMBL1673047	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	5223320	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673048	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	5223321	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(C(=O)N2CCC(N3CCCC3)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673049	=	Inhibition	%	92.0	CHEMBL5332	Homo sapiens	INH	%	92.0
	5223322	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(C(=O)NCCN(C)C)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673050	=	Inhibition	%	74.0	CHEMBL5332	Homo sapiens	INH	%	74.0
	5223323	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	CCN1c2ccccc2C(=O)N(C)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc21		CHEMBL1673051	=	Inhibition	%	79.0	CHEMBL5332	Homo sapiens	INH	%	79.0
	5223324	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C(C)C)c1ccccc1C(=O)N2C		CHEMBL1673052	=	Inhibition	%	77.0	CHEMBL5332	Homo sapiens	INH	%	77.0
	5223325	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C		CHEMBL1673053	=	Inhibition	%	79.0	CHEMBL5332	Homo sapiens	INH	%	79.0
	5223326	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccc(C)cc1C(=O)N2C		CHEMBL1673054	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	5223327	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1cc(F)ccc1C(=O)N2C		CHEMBL1673055	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	5223328	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccc(Cl)cc1C(=O)N2C		CHEMBL1673056	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	5223329	CHEMBL1679301	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 0.5 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1cc(Cl)ccc1C(=O)N2C		CHEMBL1673057	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	5223330	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	=	IC50	nM	190.0	CHEMBL5332	Homo sapiens	IC50	uM	0.19
	5223331	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673040	=	IC50	nM	240.0	CHEMBL5332	Homo sapiens	IC50	uM	0.24
	5223332	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(N2CCOCC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673041	=	IC50	nM	260.0	CHEMBL5332	Homo sapiens	IC50	uM	0.26
	5223333	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(N2CCNCC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673042	=	IC50	nM	230.0	CHEMBL5332	Homo sapiens	IC50	uM	0.23
	5223334	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673043	=	IC50	nM	200.0	CHEMBL5332	Homo sapiens	IC50	uM	0.2
	5223335	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673044	=	IC50	nM	260.0	CHEMBL5332	Homo sapiens	IC50	uM	0.26
	5223336	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	Cc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673045	=	IC50	nM	280.0	CHEMBL5332	Homo sapiens	IC50	uM	0.28
	5223337	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673046	=	IC50	nM	240.0	CHEMBL5332	Homo sapiens	IC50	uM	0.24
	5223338	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21		CHEMBL1673047	=	IC50	nM	310.0	CHEMBL5332	Homo sapiens	IC50	uM	0.31
	5223339	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673048	=	IC50	nM	320.0	CHEMBL5332	Homo sapiens	IC50	uM	0.32
	5223340	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(C(=O)N2CCC(N3CCCC3)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673049	=	IC50	nM	130.0	CHEMBL5332	Homo sapiens	IC50	uM	0.13
	5223341	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(C(=O)NCCN(C)C)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673050	=	IC50	nM	240.0	CHEMBL5332	Homo sapiens	IC50	uM	0.24
	5223342	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	CCN1c2ccccc2C(=O)N(C)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc21		CHEMBL1673051	=	IC50	nM	200.0	CHEMBL5332	Homo sapiens	IC50	uM	0.2
	5223343	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C(C)C)c1ccccc1C(=O)N2C		CHEMBL1673052	=	IC50	nM	230.0	CHEMBL5332	Homo sapiens	IC50	uM	0.23
	5223344	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C		CHEMBL1673053	=	IC50	nM	200.0	CHEMBL5332	Homo sapiens	IC50	uM	0.2
	5223345	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccc(C)cc1C(=O)N2C		CHEMBL1673054	=	IC50	nM	3100.0	CHEMBL5332	Homo sapiens	IC50	uM	3.1
	5223346	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1cc(F)ccc1C(=O)N2C		CHEMBL1673055	=	IC50	nM	1320.0	CHEMBL5332	Homo sapiens	IC50	uM	1.32
	5223347	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccc(Cl)cc1C(=O)N2C		CHEMBL1673056	=	IC50	nM	1240.0	CHEMBL5332	Homo sapiens	IC50	uM	1.24
	5223348	CHEMBL1679302	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1cc(Cl)ccc1C(=O)N2C		CHEMBL1673057	=	IC50	nM	11380.0	CHEMBL5332	Homo sapiens	IC50	uM	11.38
Active	5223349	CHEMBL1679303	Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells at 1 uM by SDS-PAGE analysis relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039		Activity			CHEMBL5332	Homo sapiens	Activity		
	6340943	CHEMBL1827267	Activity of ERK5 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	93.0	CHEMBL5332	Homo sapiens	Activity	%	93.0
	7567283	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7567742	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7568213	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7568671	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7569256	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7569716	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	510.0	CHEMBL5332	Homo sapiens	Kd	nM	510.0
	7570209	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	1700.0	CHEMBL5332	Homo sapiens	Kd	nM	1700.0
	7570636	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	9900.0	CHEMBL5332	Homo sapiens	Kd	nM	9900.0
	7571232	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	3200.0	CHEMBL5332	Homo sapiens	Kd	nM	3200.0
	7571723	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7572186	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7572602	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	48.0	CHEMBL5332	Homo sapiens	Kd	nM	48.0
	7573213	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	2500.0	CHEMBL5332	Homo sapiens	Kd	nM	2500.0
	7573228	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7573704	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7574173	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7574581	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7575210	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7575681	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7576146	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7576554	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	66.0	CHEMBL5332	Homo sapiens	Kd	nM	66.0
	7576723	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7577182	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7577660	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2700.0	CHEMBL5332	Homo sapiens	Kd	nM	2700.0
	7578130	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7578535	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7578731	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7579105	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7579555	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	620.0	CHEMBL5332	Homo sapiens	Kd	nM	620.0
	7580029	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7580498	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7580901	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	6800.0	CHEMBL5332	Homo sapiens	Kd	nM	6800.0
	7581089	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7581474	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Kd	nM	620.0	CHEMBL5332	Homo sapiens	Kd	nM	620.0
	7581919	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7582390	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7583435	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7583832	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	650.0	CHEMBL5332	Homo sapiens	Kd	nM	650.0
	7584277	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7584768	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7585172	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7585765	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7586173	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7586619	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7586648	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7587102	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	110.0	CHEMBL5332	Homo sapiens	Kd	nM	110.0
	7587726	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7588145	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1100.0	CHEMBL5332	Homo sapiens	Kd	nM	1100.0
	7588627	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7589078	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7589691	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7590140	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7590614	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7591065	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7591644	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7592116	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7592589	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7593042	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	2300.0	CHEMBL5332	Homo sapiens	Kd	nM	2300.0
	7593189	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7593624	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7594096	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7594569	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7595021	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7595157	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	42.0	CHEMBL5332	Homo sapiens	Kd	nM	42.0
	7595601	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7596075	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7596546	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7596993	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1600.0	CHEMBL5332	Homo sapiens	Kd	nM	1600.0
	7597129	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7597582	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7598055	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	7598525	CHEMBL1908585	Binding constant for ERK5 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	nM	10000.0
	8003460	CHEMBL1944426	Inhibition of human Erk5 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL5332	Homo sapiens	INH	%	35.0
	8003461	CHEMBL1944426	Inhibition of human Erk5 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL5332	Homo sapiens	INH	%	35.0
	8003462	CHEMBL1944426	Inhibition of human Erk5 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL5332	Homo sapiens	INH	%	35.0
	8003463	CHEMBL1944426	Inhibition of human Erk5 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL5332	Homo sapiens	INH	%	35.0
	10838699	CHEMBL2014925	Inhibition of Erk5 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	21.0	CHEMBL5332	Homo sapiens	INH	%	21.0
	12173620	CHEMBL2213997	Inhibition of ERK5 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5332	Homo sapiens	Activity	%	100.0
	12189660	CHEMBL2215617	Binding affinity to T7-phage-tagged MAPK7 by PCR analysis	B	COC(=O)c1c(Cc2ccc(C(=O)NCCO)cc2)c(=O)c2ccc(Cl)cc2n1-c1ccccc1		CHEMBL2152382	>	Kd	nM	10000.0	CHEMBL5332	Homo sapiens	Kd	uM	10.0
Active	13306802	CHEMBL2382926	Inhibition of ERK5 autophosphorylation in sorbitol-stimulated human HeLa cells at 0.04 to 5 uM incubated for 1 hr prior to sorbitol stimulation measured after 30 mins by Western blot analysis	B	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C		CHEMBL2381340		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
	13306805	CHEMBL2382797	Inhibition of GST-tagged full length human ERK5 transfected in HEK293 cells assessed as inhibition of AP1 transcriptional activity after 24 hrs by dual luciferase reporter gene assay	B	COc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N1CCc3cccc(c31)C(=O)N2C		CHEMBL2381339	>	EC50	nM	30000.0	CHEMBL5332	Homo sapiens	EC50	uM	30.0
	13306806	CHEMBL2382797	Inhibition of GST-tagged full length human ERK5 transfected in HEK293 cells assessed as inhibition of AP1 transcriptional activity after 24 hrs by dual luciferase reporter gene assay	B	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C		CHEMBL2381340	=	EC50	nM	4200.0	CHEMBL5332	Homo sapiens	EC50	uM	4.2
	13306807	CHEMBL2384568	Inhibition of ERK5 phosphorylation in sorbitol-stimulated human HeLa cells	B	CNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cccc(CN(C)C)c1)c1ccccc1		CHEMBL2381341	=	IC50	nM	810.0	CHEMBL5332	Homo sapiens	IC50	nM	810.0
	13306808	CHEMBL2384568	Inhibition of ERK5 phosphorylation in sorbitol-stimulated human HeLa cells	B	CN(C)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)C)ccc32)c2ccccc2)c1		CHEMBL2381342	=	IC50	nM	59.0	CHEMBL5332	Homo sapiens	IC50	nM	59.0
	13342321	CHEMBL2394154	Competitive binding affinity to ERK5 (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	<	Activity	%	30.0	CHEMBL5332	Homo sapiens	Activity	%	30.0
	13439848	CHEMBL2427149	Competitive binding affinity to ERK5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	13442424	CHEMBL2427149	Competitive binding affinity to ERK5 (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL5332	Homo sapiens	INH	%	85.0
	13442497	CHEMBL2429314	Binding affinity to ERK5 (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	1500.0	CHEMBL5332	Homo sapiens	Kd	uM	1.5
	13445681	CHEMBL2427149	Competitive binding affinity to ERK5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	79.0	CHEMBL5332	Homo sapiens	INH	%	79.0
	13451668	CHEMBL2427149	Competitive binding affinity to ERK5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	100.0	CHEMBL5332	Homo sapiens	INH	%	100.0
Not Active	15062605	CHEMBL3367929	Inhibition of human Erk5 by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
	15072492	CHEMBL3379503	Inhibition of ERK5 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	74.0	CHEMBL5332	Homo sapiens	Activity	%	74.0
	15756992	CHEMBL3630491	Inhibition of ERK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	-8.59	CHEMBL5332	Homo sapiens	INH	%	-8.59
	15757731	CHEMBL3630491	Inhibition of ERK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1	Outside typical range	CHEMBL3628627	=	Inhibition	%	-20.34	CHEMBL5332	Homo sapiens	INH	%	-20.34
	15758710	CHEMBL3630491	Inhibition of ERK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	Outside typical range	CHEMBL3628628	=	Inhibition	%	-11.21	CHEMBL5332	Homo sapiens	INH	%	-11.21
	16381050	CHEMBL3736806	Inhibition of human recombinant ERK5 by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(F)c4F)cc23)CC1		CHEMBL3735506	=	IC50	nM	220.0	CHEMBL5332	Homo sapiens	IC50	uM	0.22
	16431827	CHEMBL3748181	Inhibition of human ERK5 using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5332	Homo sapiens	IC50	uM	10.0
370220	17745086	CHEMBL3888059	In vitro Erk5 : In vitro Erk5 binding assay: Ambit Kd values in nanomolar. Kd values generated by Ambit binding assay over a concentration range of the compound.	B	CN1C(=O)[C@H]2CCC[C@H]2N(C2CCCC2)c2nc(Nc3ccc4ncccc4c3)ncc21		CHEMBL3902758	=	Kd	nM	550.0	CHEMBL5332	Homo sapiens	Kd	nM	550.0
370221	17745087	CHEMBL3888059	In vitro Erk5 : In vitro Erk5 binding assay: Ambit Kd values in nanomolar. Kd values generated by Ambit binding assay over a concentration range of the compound.	B	CN1C(=O)[C@H]2CCC[C@H]2N(C2CCCC2)c2nc(Nc3ccc(C(N)=O)cc3)ncc21		CHEMBL3986079	=	Kd	nM	320.0	CHEMBL5332	Homo sapiens	Kd	nM	320.0
370222	17745088	CHEMBL3888059	In vitro Erk5 : In vitro Erk5 binding assay: Ambit Kd values in nanomolar. Kd values generated by Ambit binding assay over a concentration range of the compound.	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2		CHEMBL1672987	=	Kd	nM	670.0	CHEMBL5332	Homo sapiens	Kd	nM	670.0
370223	17745089	CHEMBL3888059	In vitro Erk5 : In vitro Erk5 binding assay: Ambit Kd values in nanomolar. Kd values generated by Ambit binding assay over a concentration range of the compound.	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	=	Kd	nM	19.0	CHEMBL5332	Homo sapiens	Kd	nM	19.0
370224	17745090	CHEMBL3888059	In vitro Erk5 : In vitro Erk5 binding assay: Ambit Kd values in nanomolar. Kd values generated by Ambit binding assay over a concentration range of the compound.	B	COc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673040	=	Kd	nM	57.0	CHEMBL5332	Homo sapiens	Kd	nM	57.0
370225	17745091	CHEMBL3888059	In vitro Erk5 : In vitro Erk5 binding assay: Ambit Kd values in nanomolar. Kd values generated by Ambit binding assay over a concentration range of the compound.	B	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673046	=	Kd	nM	80.0	CHEMBL5332	Homo sapiens	Kd	nM	80.0
370226	17745092	CHEMBL3888059	In vitro Erk5 : In vitro Erk5 binding assay: Ambit Kd values in nanomolar. Kd values generated by Ambit binding assay over a concentration range of the compound.	B	CCN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(N4CCC(O)CC4)cn3)ncc21		CHEMBL3984135	=	Kd	nM	50.0	CHEMBL5332	Homo sapiens	Kd	nM	50.0
Inactive	17915927	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915928	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915929	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915930	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915931	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915932	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915933	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915934	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915935	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915936	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915937	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915938	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915939	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915940	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17915941	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	2965.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	2965.0
Inactive	17915942	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915943	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915944	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915945	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915946	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915947	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915948	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915949	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915950	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Active	17915951	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	253.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	253.0
Inactive	17915952	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915953	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915954	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915955	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915956	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915957	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915958	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915959	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915960	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915961	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915962	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915963	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915964	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915965	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915966	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915967	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915968	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915969	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915970	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915971	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915972	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915973	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915974	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915975	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915976	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915977	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915978	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915979	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915980	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915981	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915982	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915983	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915984	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915985	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915986	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915987	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915988	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915989	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915990	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915991	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915992	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915993	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915994	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915995	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915996	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915997	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915998	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915999	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916000	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916001	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916002	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916003	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916004	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916005	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916006	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916007	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916008	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916009	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916010	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916011	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916012	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916013	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916014	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916015	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916016	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916017	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916018	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916019	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916020	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916021	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Active	17916022	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	3885.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	3885.0
Inactive	17916023	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916024	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916025	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916026	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916027	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Active	17916028	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	4413.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	4413.0
Inactive	17916029	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916030	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916031	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916032	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916033	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916034	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916035	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916036	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916037	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916038	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916039	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916040	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916041	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916042	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17916043	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	3002.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	3002.0
Inactive	17916044	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916045	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916046	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916047	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916048	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916049	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916050	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916051	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916052	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916053	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916054	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Active	17916055	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1311.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	1311.0
Inactive	17916056	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916057	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916058	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916059	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916060	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916061	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916062	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916063	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916064	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916065	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916066	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916067	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916068	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916069	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916070	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916071	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916072	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916073	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916074	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916075	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916076	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916077	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916078	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916079	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916080	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916081	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916082	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Active	17916083	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Kd	nM	9851.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	9851.0
Inactive	17916084	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916085	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916086	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916087	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916088	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916089	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916090	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916091	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916092	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916093	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916094	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916095	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916096	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916097	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916098	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916099	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916100	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916101	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916102	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916103	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916104	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916105	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916106	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916107	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916108	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916109	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916110	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916111	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916112	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916113	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916114	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916115	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916116	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916117	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916118	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916119	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916120	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916121	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916122	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916123	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916124	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916125	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916126	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916127	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916128	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916129	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916130	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916131	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916132	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916133	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916134	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Active	17916135	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	425.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	425.0
Inactive	17916136	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916137	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916138	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916139	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916140	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916141	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916142	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916143	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916144	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916145	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916146	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916147	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916148	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916149	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916150	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916151	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916152	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916153	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916154	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916155	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916156	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916157	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916158	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916159	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916160	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17916161	CHEMBL3991775	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5332	Homo sapiens	Kd apparent	nM	30000.0
	18114361	CHEMBL4025133	Inhibition of wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	99.0	CHEMBL5332	Homo sapiens	Activity	%	99.0
	18153104	CHEMBL4034322	Inhibition of ErK5 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	8.1	CHEMBL5332	Homo sapiens	INH	%	8.1
	18203657	CHEMBL4043944	Inhibition of wild-type human partial length ERK5 (M1 to A409 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	49.0	CHEMBL5332	Homo sapiens	Activity	%	49.0
	18211589	CHEMBL4045675	Inhibition of Erk5 conserved Lys2 (DLKPSNLLVNENCELK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	30.0	CHEMBL5332	Homo sapiens	INH	%	30.0
	18211822	CHEMBL4045918	Inhibition of Erk5 conserved Lys2 (DLKPSNLLVNENCELK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	27.5	CHEMBL5332	Homo sapiens	INH	%	27.5
	18232203	CHEMBL4050303	Inhibition of human ERK5 assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	39.0	CHEMBL5332	Homo sapiens	Activity	%	39.0
	18253671	CHEMBL4055120	Inhibition of wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	96.0	CHEMBL5332	Homo sapiens	Activity	%	96.0
	18253672	CHEMBL4055120	Inhibition of wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5332	Homo sapiens	Activity	%	100.0
	18274881	CHEMBL4118339	Inhibition of Erk5 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNLLVNENCELK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-10.9	CHEMBL5332	Homo sapiens	INH	%	-10.9
	18274882	CHEMBL4118339	Inhibition of Erk5 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNLLVNENCELK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	11.6	CHEMBL5332	Homo sapiens	INH	%	11.6
	18274883	CHEMBL4118339	Inhibition of Erk5 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNLLVNENCELK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	12.4	CHEMBL5332	Homo sapiens	INH	%	12.4
	18379914	CHEMBL4145797	Inhibition of MAPK7 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	1.1	CHEMBL5332	Homo sapiens	INH	%	1.1
	18379915	CHEMBL4145816	Inhibition of MAPK7 catalytic domain (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	-5.47	CHEMBL5332	Homo sapiens	INH	%	-5.47
	18379966	CHEMBL4145867	Inhibition of MAPK7 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6368.0	CHEMBL5332	Homo sapiens	IC50	nM	6368.0
	18379967	CHEMBL4145868	Inhibition of MAPK7 catalytic domain (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	121.6	CHEMBL5332	Homo sapiens	IC50	nM	121.6
Active	18410253	CHEMBL4151871	Inhibition of human ERK5 expressed in bacterial expression system at 10 uM	B	CN1C(=O)[C@H]2CCC[C@H]2N(C2CCCC2)c2nc(Nc3ccc(C(N)=O)cc3)ncc21		CHEMBL3986079		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
	18440199	CHEMBL4157023	Binding affinity to wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL5332	Homo sapiens	Activity	%	100.0
	18449892	CHEMBL4178126	Inhibition of human ERK5 (1 to 816 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	100.0	CHEMBL5332	Homo sapiens	Activity	%	100.0
	18484639	CHEMBL4185802	Binding affinity to wild-type human partial length ERK5 (M1 to A409 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	97.0	CHEMBL5332	Homo sapiens	Activity	%	97.0
	18484976	CHEMBL4185802	Binding affinity to wild-type human partial length ERK5 (M1 to A409 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	86.0	CHEMBL5332	Homo sapiens	Activity	%	86.0
	18655533	CHEMBL4230702	Binding affinity to wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	84.0	CHEMBL5332	Homo sapiens	Activity	%	84.0
	18751612	CHEMBL4264291	Binding affinity to wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	88.0	CHEMBL5332	Homo sapiens	Activity	%	88.0
	18857960	CHEMBL4307806	Binding affinity to wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL5332	Homo sapiens	Activity	%	100.0
	18937915	CHEMBL4327688	Inhibition of human ERK5 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	101.96	CHEMBL5332	Homo sapiens	Activity	%	101.96
	18937916	CHEMBL4327688	Inhibition of human ERK5 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	102.34	CHEMBL5332	Homo sapiens	Activity	%	102.34
	18938528	CHEMBL4328048	Inhibition of human ERK5 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5332	Homo sapiens	Activity	%	65.0
	18938906	CHEMBL4328412	Inhibition of human ERK5 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	11800.0	CHEMBL5332	Homo sapiens	IC50	10'-5M	1.18
	18954101	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673046	=	IC50	nM	200.0	CHEMBL5332	Homo sapiens	IC50	uM	0.2
	18954102	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4535758	=	IC50	nM	270.0	CHEMBL5332	Homo sapiens	IC50	uM	0.27
	18954103	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1ccc2ncnc(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2c1		CHEMBL4468045	=	IC50	nM	1000.0	CHEMBL5332	Homo sapiens	IC50	uM	1.0
	18954104	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc2c1		CHEMBL4450712	=	IC50	nM	150.0	CHEMBL5332	Homo sapiens	IC50	uM	0.15
	18954105	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ccnc2c1		CHEMBL4450479	=	IC50	nM	110.0	CHEMBL5332	Homo sapiens	IC50	uM	0.11
	18954106	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)nccc2c1		CHEMBL4459339	=	IC50	nM	18000.0	CHEMBL5332	Homo sapiens	IC50	uM	18.0
	18954107	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3)CC2)c2ccccc2n1		CHEMBL4445067	>	IC50	nM	20000.0	CHEMBL5332	Homo sapiens	IC50	uM	20.0
	18954108	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	Cc1cccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc12		CHEMBL4470337	=	IC50	nM	11000.0	CHEMBL5332	Homo sapiens	IC50	uM	11.0
	18954109	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	Cc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc2c1		CHEMBL4582824	=	IC50	nM	210.0	CHEMBL5332	Homo sapiens	IC50	uM	0.21
	18954110	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	Cc1ccc2ncnc(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2c1		CHEMBL4520598	=	IC50	nM	760.0	CHEMBL5332	Homo sapiens	IC50	uM	0.76
	18954111	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc2n1		CHEMBL4465121	=	IC50	nM	6700.0	CHEMBL5332	Homo sapiens	IC50	uM	6.7
	18954112	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc2cn1		CHEMBL4550759	=	IC50	nM	2170.0	CHEMBL5332	Homo sapiens	IC50	uM	2.17
	18954113	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cnc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc2c1		CHEMBL4441182	=	IC50	nM	98.0	CHEMBL5332	Homo sapiens	IC50	uM	0.098
	18954114	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3=CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4445175	>	IC50	nM	20000.0	CHEMBL5332	Homo sapiens	IC50	uM	20.0
	18954115	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(N3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4450762	=	IC50	nM	3890.0	CHEMBL5332	Homo sapiens	IC50	uM	3.89
	18954116	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(N3CCCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4447683	>	IC50	nM	20000.0	CHEMBL5332	Homo sapiens	IC50	uM	20.0
	18954117	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4cccc(OC(F)(F)F)c4)CC3)c2cc1OC		CHEMBL4584254	=	IC50	nM	7090.0	CHEMBL5332	Homo sapiens	IC50	uM	7.09
	18954118	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccccc4OC(F)(F)F)CC3)c2cc1OC		CHEMBL4587463	>	IC50	nM	20000.0	CHEMBL5332	Homo sapiens	IC50	uM	20.0
	18954119	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(Cc4ccc(OC(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4569173	>	IC50	nM	20000.0	CHEMBL5332	Homo sapiens	IC50	uM	20.0
	18954120	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1ccc(C(=O)N2CCC(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1		CHEMBL4446192	=	IC50	nM	350.0	CHEMBL5332	Homo sapiens	IC50	uM	0.35
	18954121	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	CCOc1ccc(C(=O)N2CCC(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1		CHEMBL4466294	=	IC50	nM	380.0	CHEMBL5332	Homo sapiens	IC50	uM	0.38
	18954122	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL4545407	=	IC50	nM	920.0	CHEMBL5332	Homo sapiens	IC50	uM	0.92
	18954123	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(C(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4565352	=	IC50	nM	530.0	CHEMBL5332	Homo sapiens	IC50	uM	0.53
	18954124	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(C)cc4)CC3)c2cc1OC		CHEMBL4455302	=	IC50	nM	1660.0	CHEMBL5332	Homo sapiens	IC50	uM	1.66
	18954125	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(C(C)(C)C)cc4)CC3)c2cc1OC		CHEMBL4573138	=	IC50	nM	4100.0	CHEMBL5332	Homo sapiens	IC50	uM	4.1
	18954126	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(F)cc4)CC3)c2cc1OC		CHEMBL4563747	=	IC50	nM	2750.0	CHEMBL5332	Homo sapiens	IC50	uM	2.75
	18954127	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OCCO)cc4)CC3)c2cc1OC		CHEMBL4582719	>	IC50	nM	20000.0	CHEMBL5332	Homo sapiens	IC50	uM	20.0
	18954128	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OCCN(C)C)cc4)CC3)c2cc1OC		CHEMBL4468512	>	IC50	nM	20000.0	CHEMBL5332	Homo sapiens	IC50	uM	20.0
	18954129	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(C#N)cc4)CC3)c2cc1OC		CHEMBL4437100	=	IC50	nM	9740.0	CHEMBL5332	Homo sapiens	IC50	uM	9.74
	18954130	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(S(C)(=O)=O)cc4)CC3)c2cc1OC		CHEMBL4471256	>	IC50	nM	20000.0	CHEMBL5332	Homo sapiens	IC50	uM	20.0
	18954131	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OC(F)(F)F)cn4)CC3)c2cc1OC		CHEMBL4515161	=	IC50	nM	1630.0	CHEMBL5332	Homo sapiens	IC50	uM	1.63
	18954132	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OC(F)(F)F)nc4)CC3)c2cc1OC		CHEMBL4468249	=	IC50	nM	1120.0	CHEMBL5332	Homo sapiens	IC50	uM	1.12
	18954133	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4N)CC3)ncnc2c1		CHEMBL4469661	=	IC50	nM	51.0	CHEMBL5332	Homo sapiens	IC50	uM	0.051
	18954134	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)c(N)c4)CC3)ncnc2c1		CHEMBL4544067	=	IC50	nM	170.0	CHEMBL5332	Homo sapiens	IC50	uM	0.17
	18954135	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	CC1(O)CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5)CC4)ncnc3c2)C1		CHEMBL4526317	=	IC50	nM	68.0	CHEMBL5332	Homo sapiens	IC50	uM	0.068
	18954136	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	CN(C)C1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5)CC4)ncnc3c2)C1		CHEMBL4542723	=	IC50	nM	64.0	CHEMBL5332	Homo sapiens	IC50	uM	0.064
	18954137	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	O=C(c1ccc(OC(F)(F)F)cc1)N1CCC(c2ncnc3cc(N4CCOCC4)cnc23)CC1		CHEMBL4438379	=	IC50	nM	17.0	CHEMBL5332	Homo sapiens	IC50	uM	0.017
	18954138	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5)CC4)ncnc3c2)CC1		CHEMBL4550589	=	IC50	nM	54.0	CHEMBL5332	Homo sapiens	IC50	uM	0.054
	18954139	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582	=	IC50	nM	6400.0	CHEMBL5332	Homo sapiens	IC50	uM	6.4
	18954140	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(S(C)(=O)=O)c1ccccc1C(=O)N2C		CHEMBL4541479	=	IC50	nM	20.0	CHEMBL5332	Homo sapiens	IC50	uM	0.02
	18954141	CHEMBL4332025	Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin-Ahx-PPGDYSTTPGGTLFSTTPGGTRI peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by TR-FRET assay	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670	=	IC50	nM	35.0	CHEMBL5332	Homo sapiens	IC50	uM	0.035
Not Determined	18954151	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4535758		IC50			CHEMBL5332	Homo sapiens	IC50		
	18954152	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1ccc2ncnc(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2c1		CHEMBL4468045	=	IC50	nM	4100.0	CHEMBL5332	Homo sapiens	IC50	uM	4.1
	18954153	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc2c1		CHEMBL4450712	=	IC50	nM	420.0	CHEMBL5332	Homo sapiens	IC50	uM	0.42
	18954154	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ccnc2c1		CHEMBL4450479	=	IC50	nM	710.0	CHEMBL5332	Homo sapiens	IC50	uM	0.71
	18954155	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)nccc2c1		CHEMBL4459339	=	IC50	nM	29000.0	CHEMBL5332	Homo sapiens	IC50	uM	29.0
Not Determined	18954156	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3)CC2)c2ccccc2n1		CHEMBL4445067		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954157	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	Cc1cccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc12		CHEMBL4470337		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954158	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	Cc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc2c1		CHEMBL4582824		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954159	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	Cc1ccc2ncnc(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2c1		CHEMBL4520598		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954160	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc2n1		CHEMBL4465121		IC50			CHEMBL5332	Homo sapiens	IC50		
	18954161	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc2cn1		CHEMBL4550759	=	IC50	nM	10000.0	CHEMBL5332	Homo sapiens	IC50	uM	10.0
	18954162	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cnc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)ncnc2c1		CHEMBL4441182	=	IC50	nM	540.0	CHEMBL5332	Homo sapiens	IC50	uM	0.54
Not Determined	18954163	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3=CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4445175		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954164	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(N3CCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4450762		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954165	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(N3CCCN(C(=O)c4ccc(OC(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4447683		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954166	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4cccc(OC(F)(F)F)c4)CC3)c2cc1OC		CHEMBL4584254		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954167	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccccc4OC(F)(F)F)CC3)c2cc1OC		CHEMBL4587463		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954168	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(Cc4ccc(OC(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4569173		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954169	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1ccc(C(=O)N2CCC(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1		CHEMBL4446192		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954170	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	CCOc1ccc(C(=O)N2CCC(c3ncnc4cc(OC)c(OC)cc34)CC2)cc1		CHEMBL4466294		IC50			CHEMBL5332	Homo sapiens	IC50		
	18954171	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OC(C)C)cc4)CC3)c2cc1OC		CHEMBL4545407	=	IC50	nM	3750.0	CHEMBL5332	Homo sapiens	IC50	uM	3.75
Not Determined	18954172	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(C(F)(F)F)cc4)CC3)c2cc1OC		CHEMBL4565352		IC50			CHEMBL5332	Homo sapiens	IC50		
	18954173	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(C)cc4)CC3)c2cc1OC		CHEMBL4455302	=	IC50	nM	11500.0	CHEMBL5332	Homo sapiens	IC50	uM	11.5
Not Determined	18954174	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(C(C)(C)C)cc4)CC3)c2cc1OC		CHEMBL4573138		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954175	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(F)cc4)CC3)c2cc1OC		CHEMBL4563747		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954176	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OCCO)cc4)CC3)c2cc1OC		CHEMBL4582719		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954177	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OCCN(C)C)cc4)CC3)c2cc1OC		CHEMBL4468512		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954178	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(C#N)cc4)CC3)c2cc1OC		CHEMBL4437100		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954179	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(S(C)(=O)=O)cc4)CC3)c2cc1OC		CHEMBL4471256		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Determined	18954180	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OC(F)(F)F)cn4)CC3)c2cc1OC		CHEMBL4515161		IC50			CHEMBL5332	Homo sapiens	IC50		
	18954181	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1cc2ncnc(C3CCN(C(=O)c4ccc(OC(F)(F)F)nc4)CC3)c2cc1OC		CHEMBL4468249	=	IC50	nM	7640.0	CHEMBL5332	Homo sapiens	IC50	uM	7.64
	18954182	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)cc4N)CC3)ncnc2c1		CHEMBL4469661	=	IC50	nM	160.0	CHEMBL5332	Homo sapiens	IC50	uM	0.16
	18954183	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	COc1ccc2c(C3CCN(C(=O)c4ccc(OC(F)(F)F)c(N)c4)CC3)ncnc2c1		CHEMBL4544067	=	IC50	nM	360.0	CHEMBL5332	Homo sapiens	IC50	uM	0.36
	18954184	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	CC1(O)CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5)CC4)ncnc3c2)C1		CHEMBL4526317	=	IC50	nM	240.0	CHEMBL5332	Homo sapiens	IC50	uM	0.24
	18954185	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	CN(C)C1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5)CC4)ncnc3c2)C1		CHEMBL4542723	=	IC50	nM	670.0	CHEMBL5332	Homo sapiens	IC50	uM	0.67
	18954186	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	O=C(c1ccc(OC(F)(F)F)cc1)N1CCC(c2ncnc3cc(N4CCOCC4)cnc23)CC1		CHEMBL4438379	=	IC50	nM	150.0	CHEMBL5332	Homo sapiens	IC50	uM	0.15
	18954187	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5)CC4)ncnc3c2)CC1		CHEMBL4550589	=	IC50	nM	290.0	CHEMBL5332	Homo sapiens	IC50	uM	0.29
	18954188	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582	=	IC50	nM	11000.0	CHEMBL5332	Homo sapiens	IC50	uM	11.0
	18954189	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(S(C)(=O)=O)c1ccccc1C(=O)N2C		CHEMBL4541479	=	IC50	nM	86.0	CHEMBL5332	Homo sapiens	IC50	nM	86.0
	18954190	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670	=	IC50	nM	115.0	CHEMBL5332	Homo sapiens	IC50	nM	115.0
	18954191	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670	=	IC90	nM	691.0	CHEMBL5332	Homo sapiens	IC90	nM	691.0
	18954211	CHEMBL4332034	Inhibition of ERK5 in human SN12C cells transduced with MEF2-responsive transcription element assessed as reduction in MEF2 transcription by measuring luciferase signal after 16 hrs by luciferase reporter gene assay	B	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(S(C)(=O)=O)c1ccccc1C(=O)N2C		CHEMBL4541479	>	IC90	nM	30000.0	CHEMBL5332	Homo sapiens	IC90	uM	30.0
	18958877	CHEMBL4333396	Binding affinity to wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL5332	Homo sapiens	Activity	%	100.0
	18989210	CHEMBL4340752	Inhibition of recombinant human N-terminal FLAG-tagged/C-terminal His8 fused ERK5 internal fragment domain (L5 to Q397 residues) expressed in Sf9 insect ells using RBER-CHKtide as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	90000.0	CHEMBL5332	Homo sapiens	IC50	uM	90.0
	19006301	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCNC2		CHEMBL4439647	=	Inhibition	%	62.69	CHEMBL5332	Homo sapiens	INH	%	62.69
	19006302	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(Cc1ccccc1)C2		CHEMBL4558900	=	Inhibition	%	63.7	CHEMBL5332	Homo sapiens	INH	%	63.7
	19006303	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccccc1CN1CCc2c(sc(NC(=O)c3ccccc3Cl)c2C(N)=O)C1		CHEMBL4439931	=	Inhibition	%	55.27	CHEMBL5332	Homo sapiens	INH	%	55.27
	19006304	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	N#Cc1ccccc1CN1CCc2c(sc(NC(=O)c3ccccc3Cl)c2C(N)=O)C1		CHEMBL4456321	=	Inhibition	%	44.29	CHEMBL5332	Homo sapiens	INH	%	44.29
	19006305	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(Cc1ccccc1Cl)C2		CHEMBL4441956	=	Inhibition	%	65.11	CHEMBL5332	Homo sapiens	INH	%	65.11
	19006306	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(Cc1ccccc1F)C2		CHEMBL4434922	=	Inhibition	%	37.92	CHEMBL5332	Homo sapiens	INH	%	37.92
	19006307	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(Cc1ccc(Cl)cc1)C2		CHEMBL4473050	=	Inhibition	%	47.03	CHEMBL5332	Homo sapiens	INH	%	47.03
	19006308	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(Cc1ccc([N+](=O)[O-])cc1)C2		CHEMBL4462580	=	Inhibition	%	64.96	CHEMBL5332	Homo sapiens	INH	%	64.96
	19006309	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(Cc1c(Cl)cccc1Cl)C2		CHEMBL4560569	=	Inhibition	%	61.85	CHEMBL5332	Homo sapiens	INH	%	61.85
	19006310	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(Cc1ccc(Cl)cc1Cl)C2		CHEMBL4454651	=	Inhibition	%	63.1	CHEMBL5332	Homo sapiens	INH	%	63.1
	19006311	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(Cc1cc(Cl)cc(Cl)c1)C2		CHEMBL4457569	=	Inhibition	%	22.9	CHEMBL5332	Homo sapiens	INH	%	22.9
	19006312	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccc(C(F)(F)F)cc2)sc2c1CCN(Cc1ccccc1F)C2		CHEMBL4445191	=	Inhibition	%	56.8	CHEMBL5332	Homo sapiens	INH	%	56.8
	19006313	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccc(C(F)(F)F)cc2)sc2c1CCN(Cc1ccc(Cl)cc1)C2		CHEMBL4448197	=	Inhibition	%	61.13	CHEMBL5332	Homo sapiens	INH	%	61.13
	19006314	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccc(C(F)(F)F)cc2)sc2c1CCN(Cc1c(Cl)cccc1Cl)C2		CHEMBL4527699	=	Inhibition	%	38.73	CHEMBL5332	Homo sapiens	INH	%	38.73
	19006315	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccc(C(F)(F)F)cc2)sc2c1CCN(Cc1ccc(Cl)cc1Cl)C2		CHEMBL4586101	=	Inhibition	%	39.97	CHEMBL5332	Homo sapiens	INH	%	39.97
	19006316	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCN(Cc2c(Cl)cccc2Cl)C3)cc1		CHEMBL4514916	=	Inhibition	%	46.0	CHEMBL5332	Homo sapiens	INH	%	46.0
	19006317	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCN(Cc2ccc(Cl)cc2Cl)C3)cc1		CHEMBL4453354	=	Inhibition	%	52.31	CHEMBL5332	Homo sapiens	INH	%	52.31
	19006318	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2F)sc2c1CCN(Cc1cccc(Cl)c1)C2		CHEMBL4551716	=	Inhibition	%	42.47	CHEMBL5332	Homo sapiens	INH	%	42.47
	19006319	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2F)sc2c1CCN(Cc1c(Cl)cccc1Cl)C2		CHEMBL4544910	=	Inhibition	%	21.11	CHEMBL5332	Homo sapiens	INH	%	21.11
	19006320	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2F)sc2c1CCN(Cc1ccc(Cl)cc1Cl)C2		CHEMBL4456418	=	Inhibition	%	38.05	CHEMBL5332	Homo sapiens	INH	%	38.05
	19006321	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2cccc([N+](=O)[O-])c2)sc2c1CCN(Cc1c(Cl)cccc1Cl)C2		CHEMBL4579784	=	Inhibition	%	45.23	CHEMBL5332	Homo sapiens	INH	%	45.23
	19006322	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2cccc([N+](=O)[O-])c2)sc2c1CCN(Cc1ccc(Cl)cc1Cl)C2		CHEMBL4536292	=	Inhibition	%	77.9	CHEMBL5332	Homo sapiens	INH	%	77.9
	19006323	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1)C2		CHEMBL4465830	=	Inhibition	%	59.52	CHEMBL5332	Homo sapiens	INH	%	59.52
	19006324	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1cccc3ccccc13)C2		CHEMBL4542173	=	Inhibition	%	72.45	CHEMBL5332	Homo sapiens	INH	%	72.45
	19006325	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4571186	=	Inhibition	%	89.35	CHEMBL5332	Homo sapiens	INH	%	89.35
	19006326	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=O)Nc1ccccc1Cl)C2		CHEMBL4451130	=	Inhibition	%	89.92	CHEMBL5332	Homo sapiens	INH	%	89.92
	19006327	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1F)C2		CHEMBL4522209	=	Inhibition	%	70.66	CHEMBL5332	Homo sapiens	INH	%	70.66
	19006328	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1Br)C2		CHEMBL4553946	=	Inhibition	%	88.52	CHEMBL5332	Homo sapiens	INH	%	88.52
	19006329	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1I)C2		CHEMBL4446317	=	Inhibition	%	80.97	CHEMBL5332	Homo sapiens	INH	%	80.97
	19006330	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1C(F)(F)F)C2		CHEMBL4560244	=	Inhibition	%	76.61	CHEMBL5332	Homo sapiens	INH	%	76.61
	19006331	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccccc1NC(=S)N1CCc2c(sc(NC(=O)c3ccccc3Cl)c2C(N)=O)C1		CHEMBL4583980	=	Inhibition	%	59.26	CHEMBL5332	Homo sapiens	INH	%	59.26
	19006332	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	COc1ccccc1NC(=S)N1CCc2c(sc(NC(=O)c3ccccc3Cl)c2C(N)=O)C1		CHEMBL4450065	=	Inhibition	%	53.73	CHEMBL5332	Homo sapiens	INH	%	53.73
	19006333	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	CSc1ccccc1NC(=S)N1CCc2c(sc(NC(=O)c3ccccc3Cl)c2C(N)=O)C1		CHEMBL4444326	=	Inhibition	%	52.62	CHEMBL5332	Homo sapiens	INH	%	52.62
	19006334	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1-c1ccccc1)C2		CHEMBL4587399	=	Inhibition	%	40.46	CHEMBL5332	Homo sapiens	INH	%	40.46
	19006335	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccc(C(F)(F)F)cc1)C2		CHEMBL4564278	=	Inhibition	%	57.43	CHEMBL5332	Homo sapiens	INH	%	57.43
	19006336	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	COc1ccc(NC(=S)N2CCc3c(sc(NC(=O)c4ccccc4Cl)c3C(N)=O)C2)cc1		CHEMBL4525899	=	Inhibition	%	55.7	CHEMBL5332	Homo sapiens	INH	%	55.7
	19006337	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1c(Cl)cccc1Cl)C2		CHEMBL4458031	=	Inhibition	%	88.0	CHEMBL5332	Homo sapiens	INH	%	88.0
	19006338	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=O)Nc1c(Cl)cccc1Cl)C2		CHEMBL4475562	=	Inhibition	%	82.68	CHEMBL5332	Homo sapiens	INH	%	82.68
	19006339	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C2		CHEMBL4458351	=	Inhibition	%	77.44	CHEMBL5332	Homo sapiens	INH	%	77.44
	19006340	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C2		CHEMBL4444273	=	Inhibition	%	80.34	CHEMBL5332	Homo sapiens	INH	%	80.34
	19006341	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1cccnc1)C2		CHEMBL4475259	=	Inhibition	%	34.87	CHEMBL5332	Homo sapiens	INH	%	34.87
	19006342	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4443628	=	Inhibition	%	58.9	CHEMBL5332	Homo sapiens	INH	%	58.9
	19006343	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2F)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4532446	=	Inhibition	%	65.24	CHEMBL5332	Homo sapiens	INH	%	65.24
	19006344	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2F)sc2c1CCN(C(=O)Nc1ccccc1Cl)C2		CHEMBL4594065	=	Inhibition	%	54.91	CHEMBL5332	Homo sapiens	INH	%	54.91
	19006345	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Br)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4443169	=	Inhibition	%	80.46	CHEMBL5332	Homo sapiens	INH	%	80.46
	19006346	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2I)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4549819	=	Inhibition	%	80.36	CHEMBL5332	Homo sapiens	INH	%	80.36
	19006347	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2C(F)(F)F)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4448971	=	Inhibition	%	56.49	CHEMBL5332	Homo sapiens	INH	%	56.49
	19006348	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccccc1C(=O)Nc1sc2c(c1C(N)=O)CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4472029	=	Inhibition	%	53.04	CHEMBL5332	Homo sapiens	INH	%	53.04
	19006349	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	COc1ccccc1C(=O)Nc1sc2c(c1C(N)=O)CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4543617	=	Inhibition	%	53.49	CHEMBL5332	Homo sapiens	INH	%	53.49
	19006350	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	CSc1ccccc1C(=O)Nc1sc2c(c1C(N)=O)CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4470466	=	Inhibition	%	49.14	CHEMBL5332	Homo sapiens	INH	%	49.14
	19006351	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccc(C(F)(F)F)cc2)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4587077	=	Inhibition	%	57.48	CHEMBL5332	Homo sapiens	INH	%	57.48
	19006352	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccc(C(F)(F)F)cc2)sc2c1CCN(C(=O)Nc1ccccc1Cl)C2		CHEMBL4443282	=	Inhibition	%	62.17	CHEMBL5332	Homo sapiens	INH	%	62.17
	19006353	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCN(C(=S)Nc2ccccc2Cl)C3)cc1		CHEMBL4564776	=	Inhibition	%	50.35	CHEMBL5332	Homo sapiens	INH	%	50.35
	19006354	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCN(C(=O)Nc2ccccc2Cl)C3)cc1		CHEMBL4454447	=	Inhibition	%	53.8	CHEMBL5332	Homo sapiens	INH	%	53.8
	19006355	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2cccc([N+](=O)[O-])c2)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4529455	=	Inhibition	%	70.74	CHEMBL5332	Homo sapiens	INH	%	70.74
	19006356	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2cccc([N+](=O)[O-])c2)sc2c1CCN(C(=O)Nc1ccccc1Cl)C2		CHEMBL4471092	=	Inhibition	%	65.73	CHEMBL5332	Homo sapiens	INH	%	65.73
	19006357	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccncn2)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4514496	=	Inhibition	%	38.52	CHEMBL5332	Homo sapiens	INH	%	38.52
	19006358	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	CCCCCC(=O)Nc1sc2c(c1C(N)=O)CCN(C(=S)NCCCC)C2		CHEMBL4576149	=	Inhibition	%	43.27	CHEMBL5332	Homo sapiens	INH	%	43.27
	19006359	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2)sc2c1CCN(C(=S)Nc1ccccc1)C2		CHEMBL4527854	=	Inhibition	%	61.44	CHEMBL5332	Homo sapiens	INH	%	61.44
	19006360	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2F)sc2c1CCN(C(=S)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C2		CHEMBL4569048	=	Inhibition	%	77.32	CHEMBL5332	Homo sapiens	INH	%	77.32
	19006361	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Br)sc2c1CCN(C(=S)Nc1ccccc1F)C2		CHEMBL4462564	=	Inhibition	%	65.69	CHEMBL5332	Homo sapiens	INH	%	65.69
	19006362	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Br)sc2c1CCN(C(=S)Nc1ccccc1Br)C2		CHEMBL4441699	=	Inhibition	%	88.42	CHEMBL5332	Homo sapiens	INH	%	88.42
	19006363	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Br)sc2c1CCN(C(=S)Nc1ccccc1C(F)(F)F)C2		CHEMBL4551692	=	Inhibition	%	78.58	CHEMBL5332	Homo sapiens	INH	%	78.58
	19006364	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccccc1NC(=S)N1CCc2c(sc(NC(=O)c3ccccc3Br)c2C(N)=O)C1		CHEMBL4473345	=	Inhibition	%	46.67	CHEMBL5332	Homo sapiens	INH	%	46.67
	19006365	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2I)sc2c1CCN(C(=S)Nc1ccccc1Br)C2		CHEMBL4464422	=	Inhibition	%	85.46	CHEMBL5332	Homo sapiens	INH	%	85.46
	19006366	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2I)sc2c1CCN(C(=S)Nc1ccccc1C(F)(F)F)C2		CHEMBL4593793	=	Inhibition	%	64.83	CHEMBL5332	Homo sapiens	INH	%	64.83
	19006367	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	COc1ccccc1NC(=S)N1CCc2c(sc(NC(=O)c3ccccc3I)c2C(N)=O)C1		CHEMBL4446172	=	Inhibition	%	42.78	CHEMBL5332	Homo sapiens	INH	%	42.78
	19006368	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2C(F)(F)F)sc2c1CCN(C(=S)Nc1ccccc1F)C2		CHEMBL4458613	=	Inhibition	%	86.49	CHEMBL5332	Homo sapiens	INH	%	86.49
	19006369	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2C(F)(F)F)sc2c1CCN(C(=S)Nc1ccccc1Br)C2		CHEMBL4576241	=	Inhibition	%	73.31	CHEMBL5332	Homo sapiens	INH	%	73.31
	19006370	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccccc1NC(=S)N1CCc2c(sc(NC(=O)c3ccccc3C(F)(F)F)c2C(N)=O)C1		CHEMBL4517512	=	Inhibition	%	48.33	CHEMBL5332	Homo sapiens	INH	%	48.33
	19006371	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	COc1ccccc1NC(=S)N1CCc2c(sc(NC(=O)c3ccccc3C(F)(F)F)c2C(N)=O)C1		CHEMBL4525626	=	Inhibition	%	61.72	CHEMBL5332	Homo sapiens	INH	%	61.72
	19006372	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccccc1C(=O)Nc1sc2c(c1C(N)=O)CCN(C(=S)Nc1ccccc1Br)C2		CHEMBL4530315	=	Inhibition	%	54.86	CHEMBL5332	Homo sapiens	INH	%	54.86
	19006373	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccccc1C(=O)Nc1sc2c(c1C(N)=O)CCN(C(=S)Nc1ccccc1C(F)(F)F)C2		CHEMBL4536776	=	Inhibition	%	60.07	CHEMBL5332	Homo sapiens	INH	%	60.07
	19006374	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccccc1NC(=S)N1CCc2c(sc(NC(=O)c3ccccc3C)c2C(N)=O)C1		CHEMBL4514518	=	Inhibition	%	37.13	CHEMBL5332	Homo sapiens	INH	%	37.13
	19006375	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	COc1ccccc1NC(=S)N1CCc2c(sc(NC(=O)c3ccccc3OC)c2C(N)=O)C1		CHEMBL4517337	=	Inhibition	%	32.04	CHEMBL5332	Homo sapiens	INH	%	32.04
	19006376	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccc(C(F)(F)F)cc2)sc2c1CCN(C(=S)Nc1ccc(C(F)(F)F)cc1)C2		CHEMBL4520186	=	Inhibition	%	57.91	CHEMBL5332	Homo sapiens	INH	%	57.91
	19006377	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccc(C(F)(F)F)cc2)sc2c1CCN(C(=S)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C2		CHEMBL4475110	=	Inhibition	%	54.2	CHEMBL5332	Homo sapiens	INH	%	54.2
	19006378	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	Cc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCN(C(=S)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C3)cc1		CHEMBL4463942	=	Inhibition	%	70.76	CHEMBL5332	Homo sapiens	INH	%	70.76
	19006379	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2cccc([N+](=O)[O-])c2)sc2c1CCN(C(=S)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C2		CHEMBL4522633	=	Inhibition	%	82.86	CHEMBL5332	Homo sapiens	INH	%	82.86
	19006380	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	NC(=O)c1c(NC(=O)c2ccc[nH]2)sc2c1CCN(C(=S)Nc1cccnc1)C2		CHEMBL4592445	=	Inhibition	%	48.63	CHEMBL5332	Homo sapiens	INH	%	48.63
	19006381	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	O=C(Nc1ccc2[nH]nc(-c3ccncc3)c2c1)[C@@H]1CCN(CC(=O)N2CCN(c3ccc(-c4ncccn4)cc3)CC2)C1		CHEMBL3590107	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	19006382	CHEMBL4344499	Inhibition of ERK5 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673046	=	Inhibition	%	98.47	CHEMBL5332	Homo sapiens	INH	%	98.47
	19006631	CHEMBL4344505	Inhibition of wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4571186	=	Inhibition	%	87.0	CHEMBL5332	Homo sapiens	INH	%	87.0
Active	19006633	CHEMBL4344507	Inhibition of ERK5 in human MKN74 cells harboring siRNA assessed as reduction in ERK5 phosphorylation at 0.5 uM by immunofluorescence assay	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4571186		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
Active	19006635	CHEMBL4344509	Inhibition of ERK5 in human MKN74 cells harboring ERK1/2 siRNA assessed as reduction in ERK5 phosphorylation at 0.5 uM by immunofluorescence assay	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4571186		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
Active	19006637	CHEMBL4344511	Inhibition of ERK5 in human MKN74 cells assessed as reduction in ERK5 phosphorylation at T218/Y220 residue at 0.5 uM measured up to 24 hrs by Western blot analysis	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4571186		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
Active	19006639	CHEMBL4344514	Inhibition of ERK5 in human MKN74 cells harboring ERK1/2 siRNA assessed as reduction in ERK5 phosphorylation at 0.5 uM by Western blot analysis	B	NC(=O)c1c(NC(=O)c2ccccc2Cl)sc2c1CCN(C(=S)Nc1ccccc1Cl)C2		CHEMBL4571186		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
Not Active	19006640	CHEMBL4344515	Inhibition of ERK5 in human MKN74 cells harboring ERK1/2 siRNA assessed as reduction in ERK5 phosphorylation at 1 uM by Western blot analysis	B	O=C(Nc1ccc2[nH]nc(-c3ccncc3)c2c1)[C@@H]1CCN(CC(=O)N2CCN(c3ccc(-c4ncccn4)cc3)CC2)C1		CHEMBL3590107		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
Active	19006641	CHEMBL4344515	Inhibition of ERK5 in human MKN74 cells harboring ERK1/2 siRNA assessed as reduction in ERK5 phosphorylation at 1 uM by Western blot analysis	B	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673046		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
Active	19041106	CHEMBL4352367	Inhibition of human ERK5 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
	19059579	CHEMBL4357880	Binding affinity to wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	92.0	CHEMBL5332	Homo sapiens	Activity	%	92.0
	19089936	CHEMBL4365540	Inhibition of GST-tagged ERK5 (unknown origin) expressed in baculovirus expression system incubated for 90 mins by HTS assay	B	CN(C)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)C)ccc32)c2ccccc2)c1		CHEMBL2381342	=	IC50	nM	59.0	CHEMBL5332	Homo sapiens	IC50	nM	59.0
	19089938	CHEMBL4365542	Inhibition of ERK5 in human HeLa cells incubated for 15 mins prior to ATP addition by KiNativ profiling method	B	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673046	=	IC50	nM	300.0	CHEMBL5332	Homo sapiens	IC50	nM	300.0
	19089941	CHEMBL4365544	Inhibition of ERK5 in human HeLa cells by KiNativ profiling method	B	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(S(C)(=O)=O)c1ccccc1C(=O)N2C		CHEMBL4541479	=	IC50	nM	8.0	CHEMBL5332	Homo sapiens	IC50	nM	8.0
	19089942	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(c1ccccc1)c1c[nH]c(C(=O)NCc2ccncc2)c1		CHEMBL4572385	=	IC50	nM	40000.0	CHEMBL5332	Homo sapiens	IC50	uM	40.0
	19089943	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(NCc1ccncc1)c1cc(C(=O)c2ccccc2F)c[nH]1		CHEMBL4526143	=	IC50	nM	5900.0	CHEMBL5332	Homo sapiens	IC50	uM	5.9
	19089944	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(c1cccc(F)c1)c1c[nH]c(C(=O)NCc2ccncc2)c1	Outside typical range	CHEMBL4592573	>	IC50	nM	120000.0	CHEMBL5332	Homo sapiens	IC50	uM	120.0
	19089945	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(c1ccc(F)cc1)c1c[nH]c(C(=O)NCc2ccncc2)c1	Outside typical range	CHEMBL4568094	>	IC50	nM	120000.0	CHEMBL5332	Homo sapiens	IC50	uM	120.0
	19089946	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(NCc1ccncc1)c1cc(C(=O)c2ccccc2Cl)c[nH]1		CHEMBL4463304	=	IC50	nM	15000.0	CHEMBL5332	Homo sapiens	IC50	uM	15.0
	19089947	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(c1cccc(Cl)c1)c1c[nH]c(C(=O)NCc2ccncc2)c1		CHEMBL4578343	=	IC50	nM	6300.0	CHEMBL5332	Homo sapiens	IC50	uM	6.3
	19089948	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(c1ccc(Cl)cc1)c1c[nH]c(C(=O)NCc2ccncc2)c1	Outside typical range	CHEMBL4524821	>	IC50	nM	120000.0	CHEMBL5332	Homo sapiens	IC50	uM	120.0
	19089949	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(NCc1ccncc1)c1cc(C(=O)c2cccc(F)c2F)c[nH]1		CHEMBL4458451	=	IC50	nM	7000.0	CHEMBL5332	Homo sapiens	IC50	uM	7.0
	19089950	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(NCc1ccncc1)c1cc(C(=O)c2c(F)cccc2F)c[nH]1		CHEMBL4449117	=	IC50	nM	30000.0	CHEMBL5332	Homo sapiens	IC50	uM	30.0
	19089951	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(NCc1ccncc1)c1cc(C(=O)c2c(Cl)cccc2Cl)c[nH]1		CHEMBL4452485	=	IC50	nM	4400.0	CHEMBL5332	Homo sapiens	IC50	uM	4.4
	19089952	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(Nc1ccncc1)c1cc(C(=O)c2c(F)cccc2F)c[nH]1		CHEMBL4443724	=	IC50	nM	900.0	CHEMBL5332	Homo sapiens	IC50	uM	0.9
	19089953	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2F)c[nH]1		CHEMBL4515859	=	IC50	nM	1100.0	CHEMBL5332	Homo sapiens	IC50	uM	1.1
	19089954	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(Nc1ccncc1)c1cc(C(=O)c2c(F)cccc2Cl)c[nH]1		CHEMBL4557683	=	IC50	nM	600.0	CHEMBL5332	Homo sapiens	IC50	uM	0.6
	19089955	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Cl)c[nH]1		CHEMBL4453232	=	IC50	nM	600.0	CHEMBL5332	Homo sapiens	IC50	uM	0.6
	19089956	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(Nc1ccncc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4527483	=	IC50	nM	700.0	CHEMBL5332	Homo sapiens	IC50	uM	0.7
	19089957	CHEMBL4365545	Inhibition of recombinant N-terminal His-tagged human ERK5 (2 to 409 residues) co-expressed with GST-tagged human truncated MEK5DD lacking N-terminal 11 residues (13 to 448 residues) in Sf9 insect cells assessed as substrate peptide phosphorylation using (LVEPLTPSGEAPNQ(K-5FAM)-COOH as substrate incubated for 2 hrs by IMAP fluorescence polarisation assay	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	IC50	nM	820.0	CHEMBL5332	Homo sapiens	IC50	uM	0.82
	19089969	CHEMBL4365547	Inhibition of HA-tagged ERK5 (unknown origin) coexpressed with mutationally activated EGFP-MEK5D and Gal4-MEF2D in HEK293 cells assessed as reduction in MEF2 transcription by measuring luciferase signal after 20 hrs by luciferase reporter gene assay	B	O=C(Nc1ccncc1)c1cc(C(=O)c2c(F)cccc2F)c[nH]1		CHEMBL4443724	=	IC50	nM	8000.0	CHEMBL5332	Homo sapiens	IC50	uM	8.0
	19089970	CHEMBL4365547	Inhibition of HA-tagged ERK5 (unknown origin) coexpressed with mutationally activated EGFP-MEK5D and Gal4-MEF2D in HEK293 cells assessed as reduction in MEF2 transcription by measuring luciferase signal after 20 hrs by luciferase reporter gene assay	B	O=C(Nc1ccncc1)c1cc(C(=O)c2c(F)cccc2Cl)c[nH]1		CHEMBL4557683	=	IC50	nM	2300.0	CHEMBL5332	Homo sapiens	IC50	uM	2.3
	19089971	CHEMBL4365547	Inhibition of HA-tagged ERK5 (unknown origin) coexpressed with mutationally activated EGFP-MEK5D and Gal4-MEF2D in HEK293 cells assessed as reduction in MEF2 transcription by measuring luciferase signal after 20 hrs by luciferase reporter gene assay	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Cl)c[nH]1		CHEMBL4453232	=	IC50	nM	4000.0	CHEMBL5332	Homo sapiens	IC50	uM	4.0
	19089972	CHEMBL4365547	Inhibition of HA-tagged ERK5 (unknown origin) coexpressed with mutationally activated EGFP-MEK5D and Gal4-MEF2D in HEK293 cells assessed as reduction in MEF2 transcription by measuring luciferase signal after 20 hrs by luciferase reporter gene assay	B	O=C(Nc1ccncc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4527483	=	IC50	nM	4000.0	CHEMBL5332	Homo sapiens	IC50	uM	4.0
	19089973	CHEMBL4365547	Inhibition of HA-tagged ERK5 (unknown origin) coexpressed with mutationally activated EGFP-MEK5D and Gal4-MEF2D in HEK293 cells assessed as reduction in MEF2 transcription by measuring luciferase signal after 20 hrs by luciferase reporter gene assay	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	IC50	nM	3000.0	CHEMBL5332	Homo sapiens	IC50	uM	3.0
	19090150	CHEMBL4365724	Inhibition of wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	2.6	CHEMBL5332	Homo sapiens	Activity	%	2.6
	19090458	CHEMBL4366030	Inhibition of ERK5 (unknown origin) using R7129 as substrate incubated for 2 hrs by IMAP fluorescence polarization analysis	B	O=C(NCc1ccncc1)c1cc(C(=O)c2cccc(Cl)c2Cl)c[nH]1		CHEMBL4443714	=	IC50	nM	2000.0	CHEMBL5332	Homo sapiens	IC50	uM	2.0
	19091921	CHEMBL4366395	Inhibition of human ERK5 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-7.53	CHEMBL5332	Homo sapiens	INH	%	-7.53
	19133353	CHEMBL4375341	Binding affinity to wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system measured after 1 hr by kinomescan method	B	O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL4445812	=	Kd	nM	5320.0	CHEMBL5332	Homo sapiens	Kd	uM	5.32
	19159407	CHEMBL4382511	Binding affinity to wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	37.0	CHEMBL5332	Homo sapiens	Activity	%	37.0
	19191600	CHEMBL4389230	Inhibition of wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL5332	Homo sapiens	INH	%	100.0
	19191893	CHEMBL4389707	Inhibition of wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL5332	Homo sapiens	INH	%	100.0
	19199889	CHEMBL4391333	Binding affinity to wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	57.0	CHEMBL5332	Homo sapiens	Activity	%	57.0
	19266417	CHEMBL4405367	Inhibition of wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5332	Homo sapiens	INH	%	50.0
	19292312	CHEMBL4411563	Inhibition of N-terminal GST tagged human ERK5 (1 to 398 residues) cytoplasmic domain expressed in Escherichia coli at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	63.0	CHEMBL5332	Homo sapiens	INH	%	63.0
	20640593	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	=	Inhibition	%	96.0	CHEMBL5332	Homo sapiens	INH	%	96.0
	20640594	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCOCC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673041	=	Inhibition	%	97.0	CHEMBL5332	Homo sapiens	INH	%	97.0
	20640595	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCNCC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673042	=	Inhibition	%	98.0	CHEMBL5332	Homo sapiens	INH	%	98.0
	20640596	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCN(C3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL4648454	=	Inhibition	%	97.0	CHEMBL5332	Homo sapiens	INH	%	97.0
	20640597	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(N4CCC(O)CC4)cc3)ncc21		CHEMBL4649424	=	Inhibition	%	97.0	CHEMBL5332	Homo sapiens	INH	%	97.0
	20640598	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	Cc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL4634025	=	Inhibition	%	96.0	CHEMBL5332	Homo sapiens	INH	%	96.0
	20640599	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673040	=	Inhibition	%	98.0	CHEMBL5332	Homo sapiens	INH	%	98.0
	20640600	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673046	=	Inhibition	%	96.0	CHEMBL5332	Homo sapiens	INH	%	96.0
	20640601	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	CC(C)Oc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL4632948	=	Inhibition	%	68.0	CHEMBL5332	Homo sapiens	INH	%	68.0
	20640602	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(NS(C)(=O)=O)cc3)ncc21		CHEMBL4646447	=	Inhibition	%	98.0	CHEMBL5332	Homo sapiens	INH	%	98.0
Not Determined	20640603	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(NS(C)(=O)=O)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL4636475		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
	20640604	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21		CHEMBL1673047	=	Inhibition	%	98.0	CHEMBL5332	Homo sapiens	INH	%	98.0
	20640605	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3cccc(S(N)(=O)=O)c3)ncc21		CHEMBL3904942	=	Inhibition	%	95.0	CHEMBL5332	Homo sapiens	INH	%	95.0
	20640606	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(C(=O)N2CCN(C3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL4647792	=	Inhibition	%	97.0	CHEMBL5332	Homo sapiens	INH	%	97.0
	20640607	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673048	=	Inhibition	%	91.0	CHEMBL5332	Homo sapiens	INH	%	91.0
	20640608	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	CCOc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C		CHEMBL2381340	=	Inhibition	%	94.0	CHEMBL5332	Homo sapiens	INH	%	94.0
	20640609	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	CCN1c2ccccc2C(=O)N(C)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc21		CHEMBL1673051	=	Inhibition	%	97.0	CHEMBL5332	Homo sapiens	INH	%	97.0
	20640610	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C(C)C)c1ccccc1C(=O)N2C		CHEMBL1673052	=	Inhibition	%	99.0	CHEMBL5332	Homo sapiens	INH	%	99.0
	20640611	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C		CHEMBL1673053	=	Inhibition	%	98.0	CHEMBL5332	Homo sapiens	INH	%	98.0
	20640612	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1ccccc1)c1ccccc1C(=O)N2C		CHEMBL4645267	=	Inhibition	%	94.0	CHEMBL5332	Homo sapiens	INH	%	94.0
	20640613	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1nc(C)c2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL4638880	=	Inhibition	%	58.0	CHEMBL5332	Homo sapiens	INH	%	58.0
	20640614	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccc(C)cc1C(=O)N2C		CHEMBL1673054	=	Inhibition	%	77.0	CHEMBL5332	Homo sapiens	INH	%	77.0
	20640615	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccc(Cl)cc1C(=O)N2C		CHEMBL1673056	=	Inhibition	%	80.0	CHEMBL5332	Homo sapiens	INH	%	80.0
	20640616	CHEMBL4612963	Inhibition of ERK5 (unknown origin) at 10 uM by cell-based KiNativ profiling method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1cc(Cl)ccc1C(=O)N2C		CHEMBL1673057	=	Inhibition	%	34.0	CHEMBL5332	Homo sapiens	INH	%	34.0
	20640653	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	=	IC50	nM	87.0	CHEMBL5332	Homo sapiens	IC50	nM	87.0
	20640654	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673048	=	IC50	nM	320.0	CHEMBL5332	Homo sapiens	IC50	nM	320.0
	20640655	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	CCN1c2ccccc2C(=O)N(C)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc21		CHEMBL1673051	=	IC50	nM	66.0	CHEMBL5332	Homo sapiens	IC50	nM	66.0
	20640656	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C(C)C)c1ccccc1C(=O)N2C		CHEMBL1673052	=	IC50	nM	98.0	CHEMBL5332	Homo sapiens	IC50	nM	98.0
	20640657	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	CCC(C)N1c2ccccc2C(=O)N(C)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc21		CHEMBL4648947	=	IC50	nM	222.0	CHEMBL5332	Homo sapiens	IC50	nM	222.0
	20640658	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCC1)c1ccccc1C(=O)N2C		CHEMBL4636072	=	IC50	nM	79.0	CHEMBL5332	Homo sapiens	IC50	nM	79.0
	20640659	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)c1ccccc1C(=O)N2C		CHEMBL1673053	=	IC50	nM	146.0	CHEMBL5332	Homo sapiens	IC50	nM	146.0
	20640660	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(NS(C)(=O)=O)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL4636475	=	IC50	nM	276.0	CHEMBL5332	Homo sapiens	IC50	nM	276.0
	20640661	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1nc(C)c2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL4638880	>	IC50	nM	10000.0	CHEMBL5332	Homo sapiens	IC50	nM	10000.0
	20640662	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccc(C)cc1C(=O)N2C		CHEMBL1673054	=	IC50	nM	3100.0	CHEMBL5332	Homo sapiens	IC50	nM	3100.0
	20640663	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccc(Cl)cc1C(=O)N2C		CHEMBL1673056	=	IC50	nM	1240.0	CHEMBL5332	Homo sapiens	IC50	nM	1240.0
	20640664	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1cc(Cl)ccc1C(=O)N2C		CHEMBL1673057	=	IC50	nM	1138.0	CHEMBL5332	Homo sapiens	IC50	nM	1138.0
	20640665	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2		CHEMBL1672987	=	IC50	nM	1200.0	CHEMBL5332	Homo sapiens	IC50	nM	1200.0
	20640666	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	CCN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc21		CHEMBL4634326	=	IC50	nM	1200.0	CHEMBL5332	Homo sapiens	IC50	nM	1200.0
	20640667	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2CC(F)(F)F		CHEMBL4639395	=	IC50	nM	3350.0	CHEMBL5332	Homo sapiens	IC50	nM	3350.0
	20640668	CHEMBL4612964	Inhibition of ERK5 in human HeLa cells assessed as reduction in EGF-induced ERK5 autophosphorylation pretreated for 1 hr followed by EGF stimulation and measured after 17 mins by 32p kinase assay	B	CCN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)ncc21		CHEMBL4643632	=	IC50	nM	482.0	CHEMBL5332	Homo sapiens	IC50	nM	482.0
	22423631	CHEMBL4674391	Inhibition of human ERK5 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	99.03	CHEMBL5332	Homo sapiens	Activity	%	99.03
	22423632	CHEMBL4674391	Inhibition of human ERK5 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	101.63	CHEMBL5332	Homo sapiens	Activity	%	101.63
	22843752	CHEMBL4720738	Inhibition of human ERK5 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5520.0	CHEMBL5332	Homo sapiens	IC50	10^-6M	5.52
	22844104	CHEMBL4721090	Inhibition of human ERK5 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	97.6	CHEMBL5332	Homo sapiens	Activity	%	97.6
	22844913	CHEMBL4721588	Inhibition of wild-type human partial length ERK5 (M1 to A409 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	99.08	CHEMBL5332	Homo sapiens	Activity	%	99.08
	22855328	CHEMBL4724696	Inhibition of recombinant human GST-tagged ERK5 (1 to 398 assessed as phosphorylated peptide substrate incubated for 60 mins by TR-FRET based biochemical assay	B	Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCNC(=O)COc2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5)CC4)ncnc3c2)C(C)(C)C)cc1		CHEMBL4779321	=	IC50	nM	1230.0	CHEMBL5332	Homo sapiens	IC50	uM	1.23
	22856028	CHEMBL4724823	Inhibition of ERK5 (unknown origin)	B	CN1C(=O)c2ccccc2N(C)c2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4788469	=	IC50	nM	89.0	CHEMBL5332	Homo sapiens	IC50	uM	0.08900000000000001
	22856029	CHEMBL4724823	Inhibition of ERK5 (unknown origin)	B	CCOc1cc(C(=O)N2CCC(N3CCCC3)CC2)ccc1Nc1cc2c(cn1)N(C)C(=O)c1ccccc1N2C		CHEMBL4757477	=	IC50	nM	11.0	CHEMBL5332	Homo sapiens	IC50	uM	0.011000000000000001
Not Determined	22856060	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CN1C(=O)c2ccccc2S(=O)(=O)c2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4795695		IC50			CHEMBL5332	Homo sapiens	IC50		
	22856061	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CN1C(=O)c2c(F)ccc(F)c2Oc2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4745137	=	IC50	nM	213.0	CHEMBL5332	Homo sapiens	IC50	uM	0.213
	22856062	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CN1C(=O)c2c(F)cccc2Oc2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4763016	=	IC50	nM	131.0	CHEMBL5332	Homo sapiens	IC50	uM	0.131
	22856063	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	COc1cccc2c1Oc1cc(N[C@H]3CC[C@H](O)CC3)ncc1N(C)C2=O		CHEMBL4758899	=	IC50	nM	1100.0	CHEMBL5332	Homo sapiens	IC50	uM	1.1
	22856064	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CN1C(=O)c2cccc(Cl)c2Oc2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4788992	=	IC50	nM	1050.0	CHEMBL5332	Homo sapiens	IC50	uM	1.05
	22856065	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CN1C(=O)c2cccc(F)c2Oc2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4790464	=	IC50	nM	393.0	CHEMBL5332	Homo sapiens	IC50	uM	0.39299999999999996
Not Determined	22856066	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CN1C(=O)c2ccccc2Sc2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4747935		IC50			CHEMBL5332	Homo sapiens	IC50		
	22856067	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CN1C(=O)c2ccccc2Oc2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4796417	=	IC50	nM	266.0	CHEMBL5332	Homo sapiens	IC50	uM	0.266
	22856068	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CCO[C@@H]1CCCC[C@@H]1Nc1cc2c(cn1)N(C)C(=O)c1ccccc1N2C		CHEMBL4798210	>	IC50	nM	10000.0	CHEMBL5332	Homo sapiens	IC50	uM	10.0
	22856069	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CCO[C@H]1CC[C@H](Nc2cc3c(cn2)N(C)C(=O)c2ccccc2N3C)CC1		CHEMBL4800629	=	IC50	nM	81.0	CHEMBL5332	Homo sapiens	IC50	uM	0.081
	22856070	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CN1C(=O)c2ccccc2N(C)c2cc(N[C@H]3CC[C@@H](O)CC3)ncc21		CHEMBL4747052	=	IC50	nM	2230.0	CHEMBL5332	Homo sapiens	IC50	uM	2.23
	22856071	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CN1C(=O)c2ccccc2N(C)c2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4788469	=	IC50	nM	89.0	CHEMBL5332	Homo sapiens	IC50	uM	0.08900000000000001
Not Determined	22856072	CHEMBL4724828	Inhibition of recombinant human ERK5 using myelin basic protein as substrate by [gamm33P]ATP based HotSpot radiometric assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461		IC50			CHEMBL5332	Homo sapiens	IC50		
Not Active	22909940	CHEMBL4734074	Inhibition of recombinant human full length GST-tagged MAPK7 expressed in baculovirus expression system using serine/threonine-04 peptide as substrate at 10 uM by Z'-LYTE assay	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
Not Active	22909941	CHEMBL4734074	Inhibition of recombinant human full length GST-tagged MAPK7 expressed in baculovirus expression system using serine/threonine-04 peptide as substrate at 10 uM by Z'-LYTE assay	B	Clc1cccc(CSc2ncnc3[nH]cnc23)c1		CHEMBL4754930		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
Not Active	22909942	CHEMBL4734074	Inhibition of recombinant human full length GST-tagged MAPK7 expressed in baculovirus expression system using serine/threonine-04 peptide as substrate at 10 uM by Z'-LYTE assay	B	Brc1ccccc1CSc1ncnc2[nH]cnc12		CHEMBL4776788		Inhibition	%		CHEMBL5332	Homo sapiens	INH		
	23122279	CHEMBL4804719	Inhibition of ERK5 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-2800.0	CHEMBL5332	Homo sapiens	IC50	uM	-2.8
	23122280	CHEMBL4804719	Inhibition of ERK5 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-13200.0	CHEMBL5332	Homo sapiens	IC50	uM	-13.2
	23122281	CHEMBL4804719	Inhibition of ERK5 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-6500.0	CHEMBL5332	Homo sapiens	IC50	uM	-6.5
	23122282	CHEMBL4804720	Inhibition of ERK5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL5332	Homo sapiens	INH	%	0.0
	23122283	CHEMBL4804720	Inhibition of ERK5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL5332	Homo sapiens	INH	%	0.0
	23122284	CHEMBL4804720	Inhibition of ERK5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL5332	Homo sapiens	INH	%	0.0
	23122565	CHEMBL4804916	Inhibition of human ERK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	94.0	CHEMBL5332	Homo sapiens	Activity	%	94.0
	23123260	CHEMBL4805504	Inhibition of human ERK5 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	86.0	CHEMBL5332	Homo sapiens	Activity	%	86.0
	23123631	CHEMBL4805875	Inhibition of DNA-tagged human ERK5 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	97.0	CHEMBL5332	Homo sapiens	Activity	%	97.0
	23124258	CHEMBL4806331	Inhibition of ERK5 (unknown origin) at 10 uM relative to control	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	Inhibition	%	0.0	CHEMBL5332	Homo sapiens	INH	%	0.0
	23124610	CHEMBL4806521	Inhibition of human ERK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	59.0	CHEMBL5332	Homo sapiens	Activity	%	59.0
	23124611	CHEMBL4806521	Inhibition of human ERK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL5332	Homo sapiens	Activity	%	98.0
	23128089	CHEMBL4807838	Inhibition of ERK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5332	Homo sapiens	Activity	%	75.0
	23128090	CHEMBL4807838	Inhibition of ERK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5332	Homo sapiens	Activity	%	75.0
	23128091	CHEMBL4807838	Inhibition of ERK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5332	Homo sapiens	Activity	%	75.0
Not Active	23317400	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	88.0	CHEMBL5332	Homo sapiens	% Control	%	88.0
Not Active	23317868	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23318537	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	93.0	CHEMBL5332	Homo sapiens	% Control	%	93.0
Not Active	23319018	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	93.0	CHEMBL5332	Homo sapiens	% Control	%	93.0
Not Active	23319655	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23320130	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23320808	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23321276	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23321906	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	97.0	CHEMBL5332	Homo sapiens	% Control	%	97.0
Not Active	23322374	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	93.0	CHEMBL5332	Homo sapiens	% Control	%	93.0
Not Active	23323063	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23323531	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23324385	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	90.0	CHEMBL5332	Homo sapiens	% Control	%	90.0
Not Active	23325020	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23325488	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23326135	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	83.0	CHEMBL5332	Homo sapiens	% Control	%	83.0
Not Active	23326603	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	92.0	CHEMBL5332	Homo sapiens	% Control	%	92.0
Not Active	23327303	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	99.0	CHEMBL5332	Homo sapiens	% Control	%	99.0
Not Active	23327771	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	97.0	CHEMBL5332	Homo sapiens	% Control	%	97.0
Not Active	23328358	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	95.0	CHEMBL5332	Homo sapiens	% Control	%	95.0
Not Active	23328826	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Active	23329596	CHEMBL4880938	Cellular luciferase reporter assay using the SN12C-MEF2-luc cell line and ONE-Glo	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		IC50	nM	115.0	CHEMBL5332	Homo sapiens	IC50	nM	115.0
Not Active	23329612	CHEMBL4880938	Cellular luciferase reporter assay using the SN12C-MEF2-luc cell line and ONE-Glo	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1	Non standard unit for type	CHEMBL4455582		IC50	M	11.0	CHEMBL5332	Homo sapiens	IC50	M	11.0
Active	23329772	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	0.1	CHEMBL5332	Homo sapiens	% Control	%	0.1
Slightly Active	23330240	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	22.0	CHEMBL5332	Homo sapiens	% Control	%	22.0
Not Active	23330996	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23331464	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	87.0	CHEMBL5332	Homo sapiens	% Control	%	87.0
Not Active	23332051	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23332517	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	90.0	CHEMBL5332	Homo sapiens	% Control	%	90.0
Not Active	23333235	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23333874	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	97.0	CHEMBL5332	Homo sapiens	% Control	%	97.0
Not Active	23334342	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23335321	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	82.0	CHEMBL5332	Homo sapiens	% Control	%	82.0
Not Active	23335789	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23336416	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23336884	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	98.0	CHEMBL5332	Homo sapiens	% Control	%	98.0
Not Active	23337965	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	90.0	CHEMBL5332	Homo sapiens	% Control	%	90.0
Not Active	23338433	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	97.0	CHEMBL5332	Homo sapiens	% Control	%	97.0
Not Active	23339045	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	97.0	CHEMBL5332	Homo sapiens	% Control	%	97.0
Not Active	23339513	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	81.0	CHEMBL5332	Homo sapiens	% Control	%	81.0
Not Active	23340150	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	75.0	CHEMBL5332	Homo sapiens	% Control	%	75.0
Not Active	23340618	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23341275	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23341743	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	89.0	CHEMBL5332	Homo sapiens	% Control	%	89.0
Not Active	23342359	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	78.0	CHEMBL5332	Homo sapiens	% Control	%	78.0
Not Active	23342827	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23343457	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23343925	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	87.0	CHEMBL5332	Homo sapiens	% Control	%	87.0
Not Active	23344563	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	86.0	CHEMBL5332	Homo sapiens	% Control	%	86.0
Not Active	23345136	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23345604	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	90.0	CHEMBL5332	Homo sapiens	% Control	%	90.0
Not Active	23346181	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	83.6	CHEMBL5332	Homo sapiens	% Control	%	83.6
Not Active	23346650	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23347256	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	85.5	CHEMBL5332	Homo sapiens	% Control	%	85.5
Not Active	23347741	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	87.9	CHEMBL5332	Homo sapiens	% Control	%	87.9
Not Active	23348320	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23348788	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	92.0	CHEMBL5332	Homo sapiens	% Control	%	92.0
Not Active	23349375	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	92.0	CHEMBL5332	Homo sapiens	% Control	%	92.0
Not Active	23349993	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	80.0	CHEMBL5332	Homo sapiens	% Control	%	80.0
Not Active	23350461	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23351066	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23351534	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	96.0	CHEMBL5332	Homo sapiens	% Control	%	96.0
Not Active	23352558	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	92.0	CHEMBL5332	Homo sapiens	% Control	%	92.0
Not Active	23353026	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	76.0	CHEMBL5332	Homo sapiens	% Control	%	76.0
Not Active	23353908	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23354376	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23355108	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23355576	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23356212	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23356680	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23357289	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	78.0	CHEMBL5332	Homo sapiens	% Control	%	78.0
Not Active	23357936	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23358404	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23358990	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	99.3	CHEMBL5332	Homo sapiens	% Control	%	99.3
Not Active	23359588	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	88.0	CHEMBL5332	Homo sapiens	% Control	%	88.0
Not Active	23360056	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	88.0	CHEMBL5332	Homo sapiens	% Control	%	88.0
Not Active	23360641	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23361109	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23361682	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	83.0	CHEMBL5332	Homo sapiens	% Control	%	83.0
Not Active	23362218	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23362686	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	88.0	CHEMBL5332	Homo sapiens	% Control	%	88.0
Not Active	23364328	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	88.0	CHEMBL5332	Homo sapiens	% Control	%	88.0
Not Active	23364796	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23365535	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	99.0	CHEMBL5332	Homo sapiens	% Control	%	99.0
Not Active	23366078	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	95.0	CHEMBL5332	Homo sapiens	% Control	%	95.0
Not Active	23366668	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	78.0	CHEMBL5332	Homo sapiens	% Control	%	78.0
Not Active	23367136	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23368014	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	96.0	CHEMBL5332	Homo sapiens	% Control	%	96.0
Not Active	23368482	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	96.0	CHEMBL5332	Homo sapiens	% Control	%	96.0
Not Active	23369081	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23369549	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	91.0	CHEMBL5332	Homo sapiens	% Control	%	91.0
Not Active	23370517	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	86.0	CHEMBL5332	Homo sapiens	% Control	%	86.0
Not Active	23370985	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23371794	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	94.0	CHEMBL5332	Homo sapiens	% Control	%	94.0
Not Active	23372262	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	94.0	CHEMBL5332	Homo sapiens	% Control	%	94.0
	23373730	CHEMBL4885507	ERK5(MAP7LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5332	Homo sapiens	pIC50		6.0
Not Active	23375689	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23376157	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23376734	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23377203	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	96.0	CHEMBL5332	Homo sapiens	% Control	%	96.0
Not Active	23378062	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	60.0	CHEMBL5332	Homo sapiens	% Control	%	60.0
Not Active	23378530	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	85.0	CHEMBL5332	Homo sapiens	% Control	%	85.0
Not Active	23379697	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	94.0	CHEMBL5332	Homo sapiens	% Control	%	94.0
Not Active	23380165	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	63.0	CHEMBL5332	Homo sapiens	% Control	%	63.0
Not Active	23380859	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23381507	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23381975	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
Not Active	23382599	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	87.0	CHEMBL5332	Homo sapiens	% Control	%	87.0
Not Active	23383067	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	78.0	CHEMBL5332	Homo sapiens	% Control	%	78.0
Not Active	23383633	CHEMBL4887289	MAPK7 (ERK5) Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	98.0	CHEMBL5332	Homo sapiens	% Ctrl	%	98.0
Not Active	23384982	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	92.0	CHEMBL5332	Homo sapiens	% Control	%	92.0
Not Active	23385449	CHEMBL4879706	KinomeScan assay: inhibition of ERK5	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL5332	Homo sapiens	% Control	%	100.0
